Question

Which of the following statements is/are correct about Favipiravir? (correct answer + 2, wrong answer - 0.50)

• A. Favipiravir is an antiviral COVID-19 drug
• B. Glenmark Pharmaceuticals under the brand name FabiFlu has launched anantiviral drug Favipiravir.
  
• C. It is India's first COVID-19 drug launched
• D. All of the above.

Answer 1

The correct option is D All of the above.

Favipiravir is an oral antiviral COVID-19 drug. It works by inhibiting a viral enzyme called RNA dependent RNA polymerase which ultimately prevents replication of virus. Glenmark Pharmaceuticals under the brand name FabiFlu has launched an antiviral drug Favipiravir. It is India's first COVID-19 drug.